Youtube
KILITCH

Kilitch Drugs(I) Ltd.

₹157.25

Score

35

Technically Neutral

Advice

Kilitch Drugs(I) Price Change Analysis

Kilitch Drugs(I) Key Statistics
  • P/E Ratio

    48.4

  • PEG Ratio

    0.2

  • Market Cap Cr

    245

  • Price to Book Ratio

    106.4

  • EPS

    3.2

  • Dividend

    0 ()

  • Relative Strength Index

    39

  • Money Flow Index

    23.34

  • MACD Signal

    -7.39

  • Average True Range

    12.53

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Kilitch Drugs(I) Synopsis

NSE-Medical-Diversified

Kilitch Drugs(I) is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 70.02 Cr. and Equity Capital is Rs. 15.49 Cr. for the Year ended 31/03/2021. Kilitch Drugs(I) Ltd. is a Public Limited Listed company incorporated on 12/05/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1992PLC066718 and registration number is 066718.
  • Market Cap

    245.03

  • Sales

    94.27

  • Shares in Float

    0.50

  • No of Funds

    1

  • Yield

    0.51

  • Book Value

    1.5

  • U/D Vol Ratio

    0.8

  • LTDebt/Equity

  • Alpha

    0.02

  • Beta

    0.74

Kilitch Drugs(I) Ownership
Kilitch Drugs(I) Management

Kilitch Drugs(I) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Kilitch Drugs(I) Financials

Kilitch Drugs(I) Technicals

EMA & SMA

CURRENT PRICE

EMA

Kilitch Drugs(I) Resistance and Support

Kilitch Drugs(I) Delivery and Volume

Kilitch Drugs(I) Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

Videos

About Company

News

FAQs

Kilitch Drugs(I) share price is

Open Demat Account